Recent progress in cancer treatment continue to offer promise for patients. Investigators are diligently exploring cutting-edge approaches, including immunotherapy , targeted therapies , and precision medicine . A key study published this week showcases the effectiveness of a experimental drug in managing advanced NSCLC. Furthermore, ongoing trials